Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump's planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback